Table 1.
Category | Classification | Descriptor | Example |
---|---|---|---|
0 | Indeterminate | Incompletely evaluated. If indicated within the patient's clinical context, follow-up [MODALITY] is advised.* | Adrenal lesion with attenuation > 10 HU on enhanced CT in patient with known malignancy. Follow-up adrenal CT or MRI recommended. |
1 | Benign | No mass. | |
2 | Benign | Benign. No further follow-up needed.† | Simple hepatic or renal cyst. |
3 | Indeterminate | Indeterminate. Future imaging follow-up may be needed. If indicated within the patient's clinical context, follow-up [MODALITY] is advised within [TIME PERIOD].*‡ | Atypical hepatic hemangioma on CTor MRI. Follow-up CT or MRI recommended in 3-6 mo. |
4 | Suspicious | Suspicious. May represent malignancy. | Enhancing hepatic mass in cirrhotic patient without other classic imaging features of hepatocellular carcinoma (eg, delayed washout). |
5 | Suspicious | Highly suspicious. Clear imaging evidence of malignancy. | New hepatic soft tissue density lesions in patient with known colorectal cancer. |
6 | Malignant | Known cancer. | Biopsy-proven cancer or metastatic lesions |
7 | Benign | Completely treated cancer. | Renal cell carcinoma, status post nephrectomy without abnormality in surgical bed. |
99 | Cannot be classified | Technically inadequate for evaluation of masses. | Unenhanced CT in cirrhotic patient. |
Note: HU = Hounsfield units.
If patient has known prior outside imaging, the following recommendation can be used: “If prior imaging studies can be provided for my review, direct comparison will be performed and an addendum will be issued to this report.”
The phrase “no further follow-up needed” may be omitted for focal masses with no malignant potential that may require follow-up (eg, abscess).
If patient is known to have scheduled follow-up at our institution, the following recommendation can be used: “This may be re-evaluated at the time of routine imaging follow-up.”